Screening Nature Bank Isolates for Activity Against Parasitic Helminths

Status
Completed
Start date
End date
Start stage
Screening
End stage
Screening
Disease
Soil-transmitted helminthiasis (STH)
Schistosomiasis
Research areas
Drug

Dr. Keiser is the Head of the Helminth Drug Development Unit at Swiss TPH. Dr. Keiser’s research is focused on drug discovery for helminth infections, and she evaluates compounds using both in vitro and in vivo assays. BVGH connected Dr. Keiser with Dr. Quinn, Director of the Eskitis Institute, who facilitated the sharing of a targeted selection of Nature Bank isolates for Dr. Keiser to screen against Schistosoma and Ancylostoma (hookworm).